XML 12 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - CAD ($)
$ in Thousands
Total
Share Capital
Convertible Debentures-Equity Component
Contributed Surplus
Accumulated Other Comprehensive (Loss) Income
Deficit
Beginning balance at Apr. 30, 2022 $ 75,286 $ 114,559 $ 103 $ 9,630 $ (2,479) $ (46,527)
Beginning balance, shares at Apr. 30, 2022 24,476,846          
Shares issued pursuant to option exercise $ 715 1,247   (532)    
Shares issued pursuant to option exercise, shares 178,725          
Shares issued pursuant to conversion of convertible debentures $ 1,315 1,418 (103)      
Shares issued pursuant to conversion of convertible debentures, shares 309,877          
Share-based payments $ 1,307     1,307    
Comprehensive loss for the period (17,541)       3,890 (21,431)
Ending balance at Jan. 31, 2023 $ 61,082 117,224   10,405 1,411 (67,958)
Ending balance, shares at Jan. 31, 2023 24,965,448          
Beginning balance at Apr. 30, 2022 $ 75,286 114,559 $ 103 9,630 (2,479) (46,527)
Beginning balance, shares at Apr. 30, 2022 24,476,846          
Ending balance at Apr. 30, 2023 $ 57,803 117,470   10,796 2,625 (73,088)
Ending balance, shares at Apr. 30, 2023 25,050,260          
Beginning balance at Oct. 31, 2022 $ 61,743 117,054   10,285 (2,337) (63,259)
Beginning balance, shares at Oct. 31, 2022 24,935,448          
Shares issued pursuant to option exercise $ 97 170   (73)    
Shares issued pursuant to option exercise, shares 30,000          
Share-based payments $ 193     193    
Comprehensive loss for the period (951)       3,748 (4,699)
Ending balance at Jan. 31, 2023 $ 61,082 117,224   10,405 1,411 (67,958)
Ending balance, shares at Jan. 31, 2023 24,965,448          
Beginning balance at Apr. 30, 2023 $ 57,803 117,470   10,796 2,625 (73,088)
Beginning balance, shares at Apr. 30, 2023 25,050,260          
Shares issued pursuant to bought deal offering of common shares $ 935 878   57    
Shares issued pursuant to bought deal offering of common shares, shares 1,265,000          
Share-based payments $ 1,298     1,298    
Comprehensive loss for the period (10,218)       (1,086) (9,132)
Ending balance at Jan. 31, 2024 $ 49,818 118,348   12,151 1,539 (82,220)
Ending balance, shares at Jan. 31, 2024 26,315,260          
Beginning balance at Oct. 31, 2023 $ 51,515 117,470   11,916 1,409 (79,280)
Beginning balance, shares at Oct. 31, 2023 25,050,260          
Shares issued pursuant to bought deal offering of common shares $ 935 878   57    
Shares issued pursuant to bought deal offering of common shares, shares 1,265,000          
Share-based payments $ 178     178    
Comprehensive loss for the period (2,810)       130 (2,940)
Ending balance at Jan. 31, 2024 $ 49,818 $ 118,348   $ 12,151 $ 1,539 $ (82,220)
Ending balance, shares at Jan. 31, 2024 26,315,260